These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8226408)

  • 1. In-vitro activity of cefepime against bacterial pathogens from hospitalized patients.
    Klugman KP; Saunders J; Khoosal M
    J Antimicrob Chemother; 1993 Jul; 32(1):164-6. PubMed ID: 8226408
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of cefepime compared with other antibiotics against major hospital bacterial pathogens].
    Hryniewicz W; Skoczyńska A; Szczypa K
    Pol Merkur Lekarski; 2001 Feb; 10(56):80-2. PubMed ID: 11320582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
    Tumah HN
    Pharmazie; 2004 Nov; 59(11):854-8. PubMed ID: 15587586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cefepime against nosocomial blood culture isolates.
    Qadri SM; Cunha BA; Ueno Y; Abumustafa F; Imambaccus H; Tullo DD; Domenico P
    J Antimicrob Chemother; 1995 Sep; 36(3):531-6. PubMed ID: 8830018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
    Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
    Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
    Sidorenko SV; Strachunskiĭ LS; Akhmedova LI; Beloborodov VB; Bogomolova NS; Bol'shakov LV; Dekhnich AV; Karabak VI; Malikov VE; Pavlova MV; Polikarpova SV; Rudnov VA; Iakovlev VP
    Antibiot Khimioter; 1999; 44(11):7-16. PubMed ID: 10629736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime activity against Pseudomonas aeruginosa: evaluation of Etest and two disc diffusion methods.
    Stes P; Goossens H
    J Antimicrob Chemother; 1996 Oct; 38(4):707-11. PubMed ID: 8937965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of cefepime and other antimicrobials: survey of European isolates.
    Thornsberry C; Brown SD; Yee YC; Bouchillon SK; Marler JK; Rich T
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():31-53. PubMed ID: 8150766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
    Vahaboglu H; Saribaş S; Akbal H; Ozturk R; Yucel A
    J Antimicrob Chemother; 1998 Aug; 42(2):269-70. PubMed ID: 9738851
    [No Abstract]   [Full Text] [Related]  

  • 12. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
    Verbist L; Glupczynski Y
    Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Klebsiella spp. to cefpirome and cefepime.
    Tuchiluş C; Poiată A; Iancu LS; Bădicuţ I; Ambăruş A; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):465-7. PubMed ID: 17802963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
    Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
    Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro activity of cefepime and other antibiotics against clinical strains of gram-negative bacteria].
    Beloborodova NV; Vostrikova TIu; Mel'ko AI
    Antibiot Khimioter; 2003; 48(7):12-5. PubMed ID: 14628572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.